Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a simple ultrasound spot miscarriage risk early?

NCT ID NCT07204028

Knowledge-focused Sponsor: Cairo University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looked at whether measuring blood flow in the corpus luteum (a temporary gland in the ovary) using Doppler ultrasound can help predict how a pregnancy will progress in the first three months. Researchers studied 120 women with early pregnancies, including some with threatened miscarriage. The goal was to see if this technique could identify pregnancies at risk of complications.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this could lead to a simple ultrasound test to identify early pregnancies at risk of miscarriage.
What could go wrong
This is a small, completed observational study, not a treatment trial. The findings may not apply to all women or lead to a reliable clinical test.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

120 people

The number who actually took part.

Started

Jan 2025

Finished

Jul 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Pregnant female aged less than 40 years at 6-12 weeks.

Ages

Up to 40 years

Sex

Female participants only

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * The age of women in the studied population was up to 40 years. * Live singleton pregnancy with gestational age 6-9 gestational weeks. * Patients with threatened miscarriage were included. Exclusion Criteria: * Ectopic pregnancy. * Multiple pregnancies. * Vesicular mole. * Miscarriage in first visit. * Fetal anomaly. * Known uterine anomalies. * Significant pre-pregnancy maternal diseases (e.g., hypertension - diabetes mellitus-systemic lupus) or known thrombophilia (e.g., antiphospholipid syndrome).

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Fetal conditions are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Fetal conditions

Contacts and locations

Locations

  • Faculty of Medicine, Cairo University

    Giza, Cairo Governorate, 4240310, Egypt

More trials for these conditions

Other studies related to the condition(s) this trial covers.